Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.

Title

Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.

Creator

DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G

Publisher

Journal Of Magnetic Resonance Imaging : JMRI

Date

2021
2021-05-20

Description

Concerns over gadolinium (Gd) retention encourage the use of lower Gd doses. However, lower Gd doses may compromise imaging performance. Higher relaxivity gadobenate may be suited to reduced dose protocols.

Subject

To compare 0.05 mmol/kg and 0.1 mmol/kg gadobenate in patients undergoing enhanced MRI of the central nervous system (CNS).

Format

Journal Article

URL Address

http://doi.org/10.1002/jmri.27731

Pages

1660-1675

Issue

5

Volume

54

NEOMED College

NEOMED College of Medicine

NEOMED Department

Department of Radiology

Update Year & Number

Jan to Aug list 2021

Citation

DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G, “Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.,” NEOMED Bibliography Database, accessed April 25, 2024, https://neomed.omeka.net/items/show/11831.